Is this a new type of primary prosopagnosia, both progressive and apperceptive?

Código QR

Is this a new type of primary prosopagnosia, both progressive and apperceptive?

Azusa Sugimoto1, Shinichi Koyama2, Akira Midorikawa3, Akinori Futamura1, Kiichi Ishiwata4, Kenji Ishii4, Michael W Miller5, Mitsuru Kawamura11Department of Neurology, Showa University School of Medicine, Tokyo, 2Design Psychology Unit, Department of Design Science, Graduate School of Engineering, Ch...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Sugimoto A, Koyama S, Midorikawa A, Futamura A, Ishiwata K, Ishii K, Miller MW, Kawamura M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/730dc9f11aab42a4be55439f17c5f87e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Perceiving “ghost” images: a unique case of visual allesthesia with hemianopsia in mitochondrial disease
por: Murakami H, et al.
Publicado: (2014)

A review on primary progressive aphasia
por: Gabriel C L&eacute;ger, et al.
Publicado: (2007)

The subjective perception of past, present, and future time in patients with Alzheimer's disease: a qualitative study
por: Shiromaru-Sugimoto A, et al.
Publicado: (2018)

Frontotemporal dementia and primary progressive aphasia, a review
por: Kirshner HS
Publicado: (2014)

Progress in perisynaptic Schwann cell and neuromuscular junction research
por: Chandler L Walker
Publicado: (2022)

Reference SVA insertion polymorphisms are associated with Parkinson’s Disease progression and differential gene expression
por: Abigail L. Pfaff, et al.
Publicado: (2021)

Attention deficits in Japanese multiple sclerosis patients with minor brain lesion loads
por: Takeda A, et al.
Publicado: (2011)

A retrospective analysis focusing on a group of patients with dual diagnosis treated by both mental health and substance use services
por: Di Lorenzo R, et al.
Publicado: (2014)

Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar&nbsp;I disorder
por: Delia Bishara, et al.
Publicado: (2009)

Rotigotine is safe and efficacious in Atypical Parkinsonism Syndromes induced by both a-synucleinopathy and tauopathy
por: Moretti DV, et al.
Publicado: (2014)

Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression
por: Kamijima K, et al.
Publicado: (2013)

Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression [Corrigendum]
por: Kamijima K, et al.
Publicado: (2013)

Synucleinopathy-associated pathogenesis in Parkinson’s disease and the potential for brain-derived neurotrophic factor
por: Kathryn M. Miller, et al.
Publicado: (2021)

Mental health status, aggression, and poor driving distinguish traffic offenders from non-offenders but health status predicts driving behavior in both groups
por: Abdoli N, et al.
Publicado: (2015)

Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
por: MA Qamar, et al.
Publicado: (2017)

SARS-CoV-2-induced autophagy dysregulation may cause neuronal dysfunction in COVID-19
por: Madepalli K Lakshmana
Publicado: (2022)

Augmentation of light therapy in difficult-to-treat depressed patients: an open-label trial in both unipolar and bipolar patients
por: Camardese G, et al.
Publicado: (2015)

Clinical preference for factors in treatment of geriatric depression
por: Riepe MW
Publicado: (2014)

Is LRRK2 the missing link between inflammatory bowel disease and Parkinson’s disease?
por: Mary K. Herrick, et al.
Publicado: (2021)

α-Synuclein-induced dysregulation of neuronal activity contributes to murine dopamine neuron vulnerability
por: Abeer Dagra, et al.
Publicado: (2021)

Author Correction: TNFα increases tyrosine hydroxylase expression in human monocytes
por: Adithya Gopinath, et al.
Publicado: (2021)

TNFα increases tyrosine hydroxylase expression in human monocytes
por: Adithya Gopinath, et al.
Publicado: (2021)

Use of a self-rating scale of the nature and severity of symptoms in Parkinson’s Disease (PRO-PD): Correlation with quality of life and existing scales of disease severity
por: Laurie K. Mischley, et al.
Publicado: (2017)

Preterm neonatal brain injury: are human amnion epithelial stem cells a pan-treatment for neuroprotection and neurorepair?
por: Joanne O Davidson, et al.
Publicado: (2022)

Reversible brain atrophy and cognitive impairment in an adolescent Japanese patient with primary adrenal Cushing’s syndrome
por: Ohara N, et al.
Publicado: (2014)

Both stimulatory and inhibitory effects of dietary 5-hydroxytryptophan and tyrosine are found on urinary excretion of serotonin and dopamine in a large human population
por: George J Trachte, et al.
Publicado: (2009)

Disability in patients consulting for anxiety or mood disorders in primary care: response to antidepressant treatment
por: G&eacute;rard A, et al.
Publicado: (2012)

Response: Sotos Syndrome and the added value of genetic workup in epilepsy surgery
por: Kenneth A. Myers
Publicado: (2021)

Fine mapping of the HLA locus in Parkinson’s disease in Europeans
por: Eric Yu, et al.
Publicado: (2021)

Diabetes mellitus and co-morbid depression: treatment with milnacipran results in significant improvement of both diseases (results from the Austrian MDDM study group)
por: Heidemarie Abrahamian, et al.
Publicado: (2009)

LRRK2 levels in immune cells are increased in Parkinson’s disease
por: D. A. Cook, et al.
Publicado: (2017)

Pathways to Parkinson’s disease: a spotlight on 14-3-3 proteins
por: E. Giusto, et al.
Publicado: (2021)

Efficacy comparison of duloxetine and SSRIs at doses approved in Japan
por: Harada E, et al.
Publicado: (2015)

Effect of triiodothyronine (T3) augmentation of acute milnacipran administration on monoamine levels: an in vivo microdialysis study in rats
por: Kitaichi Y, et al.
Publicado: (2012)

Humoral response to neurofilaments and dipeptide repeats in ALS progression
por: Fabiola Puentes, et al.
Publicado: (2021)

Novel role of STAT3 in microglia-dependent neuroinflammation after experimental subarachnoid haemorrhage
por: Gang Lu, et al.

Early constipation predicts faster dementia onset in Parkinson’s disease
por: M. Camacho, et al.
Publicado: (2021)

Microdialysis and microperfusion electrodes in neurologic disease monitoring
por: Luke A. Stangler, et al.
Publicado: (2021)

Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis
por: J. M. Hatcher-Martin, et al.
Publicado: (2021)

Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease
por: Per Odin, et al.
Publicado: (2018)